Macrogenics (MGNX) Cash from Operations (2012 - 2026)
Macrogenics (MGNX) reported Cash from Operations of 35811000.0 for Q1 2026, up 23.63% year-over-year from 28966823.47 in Q1 2025, and down 183.24% quarter-over-quarter from 43021000.0 in Q4 2025.
Macrogenics (MGNX) Cash from Operations (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Cash from Operations data on file, last reported at 35811000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 35811000.0, up 23.63% year-over-year; the trailing twelve-month figure through Mar 2026 was 69961000.0 (changed 0.49% YoY), and the FY2025 annual result was 81040000.0, down 18.53% from the prior year.
- Cash from Operations declined to 35811000.0 in Q1 2026 per MGNX's latest filing, from 43021000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 60162000.0 in Q3 2024 and troughed at 57696000.0 in Q1 2022.
- A 5-year average of 20611058.82 and a median of 35246000.0 in 2023 frame the typical range for Cash from Operations.
- On a YoY basis, Cash from Operations climbed as much as 270.69% in 2024 and fell as far as 2029.49% in 2024.
- A 5-year view of Cash from Operations shows it stood at 29320000.0 in 2022, then tumbled by 195.62% to 28037000.0 in 2023, then slumped by 36.99% to 38407000.0 in 2024, then jumped by 212.01% to 43021000.0 in 2025, then sank by 183.24% to 35811000.0 in 2026.
- Business Quant data shows MGNX's Cash from Operations at 35811000.0 in Q1 2026, 43021000.0 in Q4 2025, and 30186000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | -35.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.81 Mn |
| Mar 31, 2026 | -35.81 Mn |
| Dec 31, 2025 | 43.02 Mn |
| Dec 31, 2025 | 43.02 Mn |
| Sep 30, 2025 | -30.19 Mn |
| Sep 30, 2025 | -30.19 Mn |
| Jun 30, 2025 | -46.99 Mn |
| Jun 30, 2025 | -46.99 Mn |
| Mar 31, 2025 | -46.89 Mn |
| Mar 31, 2025 | -46.89 Mn |
| Dec 31, 2024 | -38.41 Mn |
| Dec 31, 2024 | -38.41 Mn |
| Sep 30, 2024 | 60.16 Mn |
| Sep 30, 2024 | 60.16 Mn |
| Jun 30, 2024 | -44.49 Mn |
| Jun 30, 2024 | -44.49 Mn |
| Mar 31, 2024 | -45.64 Mn |
| Mar 31, 2024 | -45.64 Mn |
| Dec 31, 2023 | -28.04 Mn |
| Dec 31, 2023 | -28.04 Mn |